Prognostication of the clinical course of heart failure in elderly patients having chronic kidney disease
- Authors: Larina V.N1, Lunev V.I1, Larin V.G1, Golovko M.G1, Sidorova V.P2
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia
- Diagnostic Clinical Center No. 1 of the Moscow Department of Healthcare
- Issue: Vol 7, No 9 (2021)
- Pages: 85-94
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288640
- DOI: https://doi.org/10.18565/therapy.2021.9.85-94
- ID: 288640
Cite item
Abstract
Full Text
About the authors
V. N Larina
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Email: larinav@mail.ru
117997, Moscow, 1 Ostrovityanova Str. Tel.: +7 (910) 473-35-66
V. I Lunev
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Email: sandvit@ya.ru
117997, Moscow, 1 Ostrovityanova Str. Tel.: +7 (910) 473-35-66
V. G Larin
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Email: larinvladimir@mail.ru
117997, Moscow, 1 Ostrovityanova Str. Tel.: +7 (910) 473-35-66
M. G Golovko
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Email: golovko_mg@rsmu.ru
117997, Moscow, 1 Ostrovityanova Str. Tel.: +7 (910) 473-35-66
V. P Sidorova
Diagnostic Clinical Center No. 1 of the Moscow Department of Healthcare
Email: kdc1@zdrav.mos.ru
117997, Moscow, 1 Ostrovityanova Str. Tel.: +7 (910) 473-35-66
References
- Seferovic P., Vardas P., Jankowska E. et al. The Heart Failure Association atlas: Heart failure epidemiology and management statistics 2019. Eur J Heart Fail. 2021; 23(6): 906-14. doi: 10.1002/ejhf.2143.
- Российское кардиологическое общество (РКО). Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 11: 4083. @@Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 11: 4083 (In Russ.). https://dx.doi.org/10.15829/1560-4071-2020-4083.
- Поляков Д.С., Фомин И.В., Беленков Ю.Н. с соавт. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021; 4: 4-14. @@Polyakov D.S., Fomin I.V., Belenkov Yu.N. et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiya = Cardiology. 2021; 4: 4-14 (In Russ.). https://dx.doi.org/10.18087/cardio.2021.4.n1628.
- Клинические рекомендации. Хроническая болезнь почек (ХБП). Ассоциация нефрологов. 2021. Рубрикатор клинических рекомендаций Минздрава России. Доступ: https://cr.minzdrav.gov.ru/schema/469_2(дата обращения - 01.11.2021). @@Clinical guidelines. Chronic kidney disease (CKD). Association of Nephrologists. 2021. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. Available at: https://cr.minzdrav.gov.ru/schema/469_2 (date of access - 01.11.2021).
- Батюшин М.М. Хроническая болезнь почек: современное состояние проблемы. Рациональная фармакотерапия в кардиологии. 2020; 6: 938-947. @@Batiushin M. Chronic kidney disease: current state of the problem. Ratsional'naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2020; 6: 938-947 (In Russ.)]. https://dx.doi.org/10.20996/1819-6446-2020-11-06.
- Ларина В.Н., Барт Б.Я., Карпенко Д.Г с соавт. Полиморбидность и ее связь с неблагоприятным течением хронической сердечной недостаточности у амбулаторных больных в возрасте 60 лет и старше. Кардиология. 2019; 12S: 25-36. @@Larina V.N., Bart B.Ya., Karpenko D.G. et al. Polymorbidity and its association with the unfavorable course of chronic heart failure in outpatients aged 60 years and older. Kardiologiya = Cardiology. 2019; 12S: 25-36 (In Russ.). https://dx.doi.org/10.18087/cardio.n431.
- United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020. Available at: https://adr.usrds.org/2020 (date of access - 01.11.2021).
- Li P., Garcia-Garcia G., Lui S. et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int. 2020; 97(2): 226-32. doi: 10.1016/j.kint.2019.12.002.
- Hill N., Fatoba S., Oke J. et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016; 11(7): e0158765. doi: 10.1371/journal.pone.0158765.
- Дудко М.Ю., Котенко О.Н., Шутов Е.В. с соавт. Эпидемиология хронической болезни почек среди жителей города Москвы. Клиническая Нефрология. 2019; 3: 37-41. @@Dudko M., Kotenko O., Shutov E. et al. Epidemiology of chronic kidney disease among residents of Moscow. Klinicheskaya nefrologiya = Clinical Nephrology. 2019; 3: 37-41 (In Russ.). https://dx.doi.org/10.18565/nephrology.2019.337-41.
- Smith D., Thorp M., Gurwitz J. et al. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction. Circ Cardiovasc Qual Outcomes. 2013; 6(3): 333-42. doi: 10.1161/circoutcomes.113.000221.
- Saeed F., Arrigain S., Schold J. et al. What are the risk factors for one-year mortality in older patients with chronic kidney disease? An analysis of the Cleveland Clinic CKD Registry. Nephron. 2018; 141(2): 98-104. doi: 10.1159/000494298.
- Hu L., Xiong Q., Chen Z. et al. Factors associated with a large decline in renal function or progression to renal insufficiency in hospitalized atrial fibrillation patients with early-stage CKD. Int Heart J. 2020; 61(2): 239-48. doi: 10.1536/ihj.19-205.
- Mewton N., Opdahl A., Choi E. et al. Left ventricular global function index by magnetic resonance imaging - a novel marker for assessment of cardiac performance for the prediction of cardiovascular events. Hypertension. 2013; 61(4): 770-78. doi: 10.1161/ hypertensionaha.111.198028.
- Nwabuo C., Moreira H., Vasconcellos H. et al. Left ventricular global function index predicts incident heart failure and cardiovascular disease in young adults: the coronary artery risk development in young adults (CARDIA) study. Eur Heart J Cardiovasc Imaging. 2018; 20(5): 533-40. doi: 10.1093/ehjci/jey123.
- Minushkina L., Brazhnik V., Chumakova O., Alekhin M. Left ventricular global function index and blood pressure parameters in untreated patients with hypertension. J Hypertens. 2021; 39(Suppl 1): e141. doi: 10.1097/01.hjh.0000745916.91045.38.
- Huang S., Xu H., Diao K. et al. Left ventricular global function index by magnetic resonance imaging - a novel marker for differentiating cardiac amyloidosis from hypertrophic cardiomyopathy. Sci Rep. 2020; 10(1): 4707. doi: 10.1038/s41598-020-61608-9.
- Cheung A., Chang T., Cushman W. et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021; 99(3): S1-S87. doi: 10.1016/j.kint.2020.11.003.
- Lang R., Badano L., Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015; 28(1): 1-39.e14. doi: 10.1016/j.echo.2014.10.003.
- Ларина В.Н., Лунев В.И., Алехин М.Н. Индекс глобальной функции левого желудочка: прогностическое значение у пациентов с хронической сердечной недостаточностью в возрасте 60 лет и старше. Кардиоваскулярная терапия и профилактика. 2020; 5: 2404. @@Larina V.N., Lunev V.I., Alekhin M.N. Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2020; 5: 2404 (In Russ.). https://dx.doi.org/10.15829/1728-8800-2020-2404.
- Eitel I., Poss J., Jobs A. et al. Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2015; 17(1): 62. doi: 10.1186/s12968-015-0161-x.
- Reinstadler S., Klug G., Feistritzer H. et al. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2015; 17(2): 169-76. doi: 10.1093/ehjci/jev129.
- Michalska-Kasiczak M., Bielecka-Dabrowa A., von Haehling S. et al. Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: An overview. Arch Med Sci. 2018; 14(4): 890-909. doi: 10.5114/aoms.2018.76279.
- Packer M., Kitzman D. Obesity-related heart failure with a preserved ejection fraction. JACC Heart Fail. 2018; 6(8): 633-39. doi: 10.1016/j.jchf.2018.01.009.
- Packer M., Lam C., Lund L. et al. Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease. Eur J Heart Fail. 2020; 22(9): 1551-67. doi: 10.1002/ejhf.1902.
- Давыдов В.В., Арехина Е.Л. Причины развития и прогрессирования кардиоренального синдрома при хронической сердечной недостаточности. Методы профилактики. Российский кардиологический журнал. 2021; 1: 4160. @@Davydov V.V., Arekhina E.L. Causes of development and progression of cardiorenal syndrome in heart failure patients. Prevention methods. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2021; 1: 4160 (In Russ.). https://dx.doi.org/10.15829/1560-4071-2021-4160.
- Ларина В.Н., Лунев В.И. Значение биомаркеров в диагностике и прогнозировании сердечной недостаточности в старшем возрасте. Архивъ внутренней медицины. 2021; 2: 98-110. @@Larina V., Lunev V. The value of biomarkers in the diagnosis and prognosis of heart failure in older age. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2021; 2: 98-110 (In Russ.). https://dx.doi.org/10.20514/2226-6704-2021-11-2-98-110.
- Кузьмин О.Б., Жежа В.В., Белянин В.В. и др. Влияние хронической болезни почек на формирование диастолической дисфункции сердца у больных ХСН с сохраненной ФВ. Кардиология. 2018; 4S: 37-45. @@Kuzmin O., Zezha V., Belyanin V. et al. Effect of chronic kidney disease on the formation of diastolic heart dysfunction in heart failure patients with preserved ejection fraction. Kardiologiia = Cardiology. 2018; 4S: 37-45 (In Russ.). https://dx.doi.org/10.18087/cardio.2451.
- Edwards N., Ferro C., Townend J. et al. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart. 2008; 94(8): 1038-43. doi: 10.1136/hrt.2007.137539.
- Unger E., Dubin R., Deo R. et al. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2015; 18(1): 103-12. doi: 10.1002/ejhf.445.
- Колегова И.И., Чернявина А.И., Козиолова Н.А. Характеристика течения хронической сердечной недостаточности и состояния органов-мишеней у больных кардиоренальным синдромом. Российский кардиологический журнал. 2018; 1: 21-26. [Kolegova I., Chernyavina A., Koziolova N. Characteristics of the chronic heart failure course and target organ condition in cardiorenal syndrome. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 1: 21-26 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2018-1-21-26.